Bibliographic Details
| Title: |
Phase II trial of bevacizumab and dose/dense chemotherapy with cisplatin and metronomic daily oral etoposide in advanced non-small-cell-lung cancer patients. |
| Authors: |
Correale P; Medical Oncology Unit, Siena University Hospital Santa Maria alle Scotte, Istituto Toscano Tumori, Italy., Botta C, Basile A, Pagliuchi M, Licchetta A, Martellucci I, Bestoso E, Apollinari S, Addeo R, Misso G, Romano O, Abbruzzese A, Lamberti M, Luzzi L, Gotti G, Rotundo MS, Caraglia M, Tagliaferri P |
| Source: |
Cancer biology & therapy [Cancer Biol Ther] 2011 Jul 15; Vol. 12 (2), pp. 112-8. Date of Electronic Publication: 2011 Jul 15. |
| Publication Type: |
Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: |
Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101137842 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1555-8576 (Electronic) Linking ISSN: 15384047 NLM ISO Abbreviation: Cancer Biol Ther Subsets: MEDLINE |
| Database: |
MEDLINE Ultimate |
